A Randomized, Open-Label, Controlled Study Evaluating the Effect of Adding Milnacipran to Pregabalin in Patients with Fibromyalgia

被引：0
|
作者：
Mease, Philip [1 ,2 ]
Farmer, Mildred V.
Trugman, Joel M. [3 ]
Gendreau, Michael R.
Reese, Jennifer [3 ]
机构：
[1] Seattle Rheumatol Associates, Seattle, WA USA
[2] Swedish Med Ctr, Englewood, CO 80110 USA
[3] Forest Res Inst, Dehra Dun, India
来源：
JOURNAL OF WOMENS HEALTH | 2011年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P107
引用
收藏
页码：493 / 493
页数：1
相关论文
共 50 条
  • [1] Effect of Adding Milnacipran to Pregabalin for the Management of Fibromyalgia: A Randomized, Open-Label, Controlled Study
    Farmer, Mildred V.
    Trugman, Joel M.
    Wang, Yong
    Gendreau, R. Michael
    [J]. NEUROLOGY, 2011, 76 (09) : A192 - A192
  • [2] Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin
    Mease, Philip J.
    Farmer, Mildred V.
    Palmer, Robert H.
    Gendreau, R. Michael
    Trugman, Joel M.
    Wang, Yong
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2013, 5 (03) : 113 - 126
  • [3] 3-Year Efficacy of Milnacipran in Patients with Fibromyalgia: An Open-Label, Flexible-Dosing Study.
    Arnold, Lesley M.
    Ma, Yimin
    Palmer, Robert H.
    Spera, Allan
    Baldecchi, Arlene
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S743 - S743
  • [4] An Open-label Study Adding Creatine Monohydrate to Ongoing Medical Regimens in Patients with the Fibromyalgia Syndrome
    Leader, Avi
    Amital, Daniella
    Rubinow, Alan
    Amital, Howard
    [J]. CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 829 - 836
  • [5] A 3-Year, Open-Label, Flexible-Dosing Study of Milnacipran for the Treatment of Fibromyalgia
    Arnold, Lesley M.
    Palmer, Robert H.
    Ma, Yimin
    [J]. CLINICAL JOURNAL OF PAIN, 2013, 29 (12): : 1021 - 1028
  • [6] Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study
    Ohta, Hiroyoshi
    Ohkura, Masayuki
    Suzuki, Makoto
    Oka, Hiroshi
    Usui, Chie
    Nishioka, Kusuki
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S792 - S792
  • [7] Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial
    Bidari, Ali
    Moazen-Zadeh, Ehsan
    Ghavidel-Parsa, Banafsheh
    Rahmani, Shahrzad
    Hosseini, Sajjad
    Hassankhani, Amir
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (01) : 149 - 158
  • [8] Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial
    Ali Bidari
    Ehsan Moazen-Zadeh
    Banafsheh Ghavidel-Parsa
    Shahrzad Rahmani
    Sajjad Hosseini
    Amir Hassankhani
    [J]. DARU Journal of Pharmaceutical Sciences, 2019, 27 : 149 - 158
  • [9] Safety and Tolerability of Milnacipran in a 3-Year, Open-Label, Flexible-Dosing Study of Patients with Fibromyalgia.
    Arnold, Lesley M.
    Ma, Yimin
    Palmer, Robert H.
    Spera, Allan
    Baldecchi, Arlene
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S742 - S743
  • [10] Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: An open-label, prospective trial
    Calandre, E. P.
    Morillas-Arques, P.
    Rodriguez-Lopez, C. M.
    Rico-Villademoros, F.
    Hidalgo, J.
    [J]. PHARMACOPSYCHIATRY, 2007, 40 (02) : 68 - 71
12345